Amadeus UK18 Sep. 2017
Amadeus UK have signed up to do a Group Skydive: a hair-raising obstacle assault course on September 24th in support of MDS UK Patient Support Group.
Amadeus, the leading provider of IT solutions to the global tourism and travel industry, are not new to giving, having donated an amazing £3,000 for MacMillan last year.
This year, they are not only fundraising for MDS UK Patient Support Group, but also doing an incredible job at raising awareness of the disease:
We are raising money for our colleague who is suffering from a cancer condition called Myelodysplastic Syndrome known as MDS, very few people are diagnosed in the UK from this condition and infact in the USA just 63 per year.
A person with MDS will suffer from chronic tiredness and weakness due to the low levels of haemoglobin in the red blood cells, which carries oxygen to the body.
This is debilitating in itself and often requires regular blood transfusions. Transfusions are time consuming and restrictive.
In MDS, platelet numbers, which prevent bleeding and bruising, can often be very low. This can result in spontaneous bleeding and bruising.
If an injury is sustained blood loss may be excessive. Clearly these factors result in many constraints and difficulties. Platelet transfusions may be required on a regular basis.
When white cells numbers become very low (as they often do in MDS) the body is unable to fight off infection normally. This results in a greater than usual incidence of infections which take longer than usual to clear and might require hospitalisation. White cells cannot be given by transfusion.
We are collecting money for the charity that is looking into new research to better manage the situation and look for extending quality of life. Our colleague has a young family and lives in Crawley in West Sussex and has been unable to work for over two years now.
For us, as a small charity, it is a dream to get such a generous fundraiser. We are extremely grateful to Amadeus for thinking of us.
All the money raised will go to ensure that all patients and families receive the attention and information they need during those particularly difficult times – straight after diagnosis, at treatment changes, time of transplant or progression of the condition./strong>